NasdaqGM - Nasdaq Real Time Price USD
Barinthus Biotherapeutics plc (BRNS)
1.0800
-0.0200
(-1.82%)
At close: May 30 at 4:00:00 PM EDT
1.0800
0.00
(0.00%)
After hours: May 30 at 4:04:14 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 3 | 3 |
| Avg. Estimate | -0.33 | -0.34 | -1.49 | -1.38 |
| Low Estimate | -0.37 | -0.39 | -1.63 | -1.69 |
| High Estimate | -0.29 | -0.29 | -1.35 | -1.19 |
| Year Ago EPS | -0.43 | -0.21 | -1.24 | -1.49 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 3 | 3 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | 14.97M | 14.97M | -- |
| Sales Growth (year/est) | 0.00% | -100.00% | -100.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.41 | -0.44 | -0.37 | -0.36 |
| EPS Actual | -0.43 | -0.21 | -0.2 | -0.49 |
| Difference | -0.02 | 0.23 | 0.17 | -0.13 |
| Surprise % | -4.03% | 52.63% | 45.38% | -36.11% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.33 | -0.34 | -1.49 | -1.38 |
| 7 Days Ago | -0.36 | -0.35 | -1.39 | -1.48 |
| 30 Days Ago | -0.36 | -0.35 | -1.39 | -1.48 |
| 60 Days Ago | -0.36 | -0.36 | -1.44 | -1.85 |
| 90 Days Ago | -0.36 | -0.36 | -1.44 | -1.85 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | -- | 1 |
| Up Last 30 Days | 1 | 1 | -- | 1 |
| Down Last 7 Days | 1 | 1 | 1 | -- |
| Down Last 30 Days | 1 | 1 | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BRNS | 23.26% | -61.90% | -20.23% | 7.81% |
| S&P 500 | 13.07% | 2.27% | 7.37% | 14.07% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/21/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 1/13/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/19/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/8/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 10/1/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/26/2024 |
Related Tickers
LYEL Lyell Immunopharma, Inc.
0.4367
+8.74%
BOLD Boundless Bio, Inc.
1.1000
-5.98%
KRON Kronos Bio, Inc.
0.6750
+0.52%
GBIO Generation Bio Co.
0.3782
-2.58%
ABUS Arbutus Biopharma Corporation
3.3600
-2.33%
ANTX AN2 Therapeutics, Inc.
1.0600
-12.40%
VOR Vor Biopharma Inc.
0.1999
+2.46%
IPSC Century Therapeutics, Inc.
0.5304
-4.78%
CARM Carisma Therapeutics, Inc.
0.1906
-4.56%
APRE Aprea Therapeutics, Inc.
1.7400
-2.79%